Investigation of several biomarkers associated with diabetic nephropathy

Experimental and Clinical Endocrinology and Diabetes

Volumn 123, Issue 1, 2015, Pages 1-6

  Jiang, Z S ^a   Jia, H X ^a   Xing, W J ^a   Han, C D ^a   Wang, J ^a   Zhang, Z J ^a   Qu, W ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

bioinformatics; diabetic nephropathy; hub genes

Indexed keywords

ALPHA ACTININ 1; BIOLOGICAL MARKER; CD14 ANTIGEN; CD163 ANTIGEN; CD24 ANTIGEN; CD52 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR2; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 8; LAMININ ALPHA4; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MATRILYSIN; MUCIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; MYC PROTEIN; PROTEIN HOMER 3; PROTEIN KINASE LCK; PROTEIN P53; RANTES; SECRETED FRIZZLED RELATED PROTEIN 1; TRANSCRIPTION FACTOR SOX4; VASCULOTROPIN A; WT1 PROTEIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETICS; HUMAN; INFLAMMATION; METABOLISM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METABOLISM; MODELS, GENETIC; SIGNAL TRANSDUCTION;

EID: 84964267301     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1385875     Document Type: Article

References (34)

1. Bell C. G., Teschendorff A. E., Rakyan V. K. et al. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics: 2010; 3 33
2. Inoki K., Mori H., Wang J. et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest: 2011; 121 2181 2196
3. Oudit G. Y., Liu G. C., Zhong J. et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes: 2010; 59 529 538
4. Hovind P., Rossing P., Johnson R. J. et al. Serum uric acid as a new player in the development of diabetic nephropathy. J Renal Nutr: 2011; 21 124 127
5. Barrett T., Troup D. B., Wilhite S. E. et al. NCBI GEO: archive for functional genomics data sets - 10 years on. Nucleic Acids Res: 2011; 39 1005 1010
6. Parkinson H., Kapushesky M., Shojatalab M. et al. ArrayExpress - a public database of microarray experiments and gene expression profiles. Nucleic Acids Res: 2007; 35 747 750
7. Schramm S. J., Campain A. E., Scolyer R. A. et al. Review and cross-validation of gene expression signatures and melanoma prognosis. J Invest Dermatol: 2012; 132 274 283
8. Timar J., Gyorffy B., Raso E. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little? Clin Exp Metastas: 2010; 27 371 387
9. Baelde H. J., Eikmans M., Doran P. P. et al. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis: 2004; 43 636 650
10. Woroniecka K. I., Park A. S., Mohtat D. et al. Transcriptome analysis of human diabetic kidney disease. Diabetes: 2011; 60 2354 2369
11. Liu W., Peng Y., Tobin D. J. A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis. PeerJ: 2013; 1 e49
12. Szklarczyk D., Franceschini A., Kuhn M. et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res: 2011; 39 561 568
13. Cline M. S., Smoot M., Cerami E. et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc: 2007; 2 2366 2382
14. Scardoni G., Laudanna C. Centralities based analysis of complex networks. New Frontiers in Graph Theory InTech Open: 2012
15. Da Wei Huang BT S., Lempicki R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc: 2008; 4 44 57
16. McCarthy D. J., Smyth G. K. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics: 2009; 25 765 771
17. Yanofsky C. M., Bickel D. R. Validation of differential gene expression algorithms: Application comparing fold-change estimation to hypothesis testing. BMC Bioinformatics: 2010; 11 63
18. Kadota K., Nakai Y., Shimizu K. A weighted average difference method for detecting differentially expressed genes from microarray data. Algorithms Mol Biol: 2008; 3 8
19. Farztdinov V., McDyer F. Distributional fold change test - a statistical approach for detecting differential expression in microarray experiments. Algorithms Mol Biol: 2012; 7 29
20. Chang W., Ma L., Lin L. et al. Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer: 2009; 125 2844 2853
21. Peng W., Wang J., Cai J. et al. Improving protein function prediction using domain and protein complexes in PPI networks. BMC Syst Biol: 2014; 8 35
22. Wright S. D., Ramos R. A., Tobias P. S. et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science: 1990; 249 1431 1433
23. Baumann C. L., Aspalter I. M., Sharif O. et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med: 2010; 207 2689 2701
24. Devitt A., Moffatt O. D., Raykundalia C. et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature: 1998; 392 505 509
25. Fernández-Real J. M., Del Pulgar S. P., Luche E. et al. CD14 modulates inflammation-driven insulin resistance. Diabetes: 2011; 60 2179 2186
26. Andia D. C., Letra A., Casarin RC V. et al. Genetic analysis of the IL8 gene polymorphism (rs4073) in generalized aggressive periodontitis. Arch Oral Biol: 2013; 58 211 217
27. Singh J. K., Simões B. M., Howell S. J. et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res: 2013; 15 210
28. He T-C, Sparks A. B., Rago C. et al. Identification of c-MYC as a target of the APC pathway. Science: 1998; 281 1509 1512
29. Hermeking H., Rago C., Schuhmacher M. et al. Identification of CDK4 as a target of c-MYC. P Natl A Sci: 2000; 97 2229 2234
30. Adhikary S., Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Bio: 2005; 6 635 645
31. Meyer N., Penn L. Z. Reflecting on 25 years with MYC. Nature Reviews Cancer: 2008; 8 976 990
32. Hirakawa S., Kodama S., Kunstfeld R. et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med: 2005; 201 1089 1099
33. Rydén L., Stendahl M., Jonsson H. et al. Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response. Breast Cancer ResTr: 2005; 89 135 143
34. Terme M., Pernot S., Marcheteau E. et al. VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer. Cancer Res: 2013; 73 539 549